H.B. Fuller (NYSE:FUL) Hits New 1-Year Low – Here’s What Happened

H.B. Fuller (NYSE:FUL) reached a new 52-week low during trading on Wednesday . The company traded as low as $59.01 and last traded at $59.47, with a volume of 9623 shares traded. The stock had previously closed at $60.10.

Wall Street Analyst Weigh In

FUL has been the topic of several recent analyst reports. JPMorgan Chase & Co. cut their price objective on H.B. Fuller from $70.00 to $60.00 and set an “underweight” rating on the stock in a report on Friday, January 17th. Vertical Research lowered shares of H.B. Fuller from a “buy” rating to a “hold” rating in a research note on Monday, January 6th. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of H.B. Fuller from $75.00 to $72.00 and set a “buy” rating for the company in a research report on Wednesday, January 22nd. Finally, Citigroup cut their price objective on shares of H.B. Fuller from $78.00 to $68.00 and set a “neutral” rating on the stock in a research report on Friday, January 3rd. One analyst has rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $75.60.

H.B. Fuller Stock Performance

The company has a market capitalization of $3.13 billion, a price-to-earnings ratio of 24.77, a P/E/G ratio of 1.13 and a beta of 1.42. The stock’s 50 day moving average price is $63.95 and its 200 day moving average price is $73.39. The company has a current ratio of 1.81, a quick ratio of 1.16 and a debt-to-equity ratio of 1.10.

H.B. Fuller (NYSE:FUL) last posted its quarterly earnings results on Wednesday, January 15th. The specialty chemicals company reported $0.92 earnings per share for the quarter, missing the consensus estimate of $1.00 by ($0.08). H.B. Fuller had a return on equity of 12.01% and a net margin of 3.65%. The company had revenue of $923.00 million for the quarter, compared to analyst estimates of $916.84 million. During the same period last year, the firm earned $1.32 EPS. The firm’s revenue for the quarter was up 2.2% compared to the same quarter last year. Analysts expect that H.B. Fuller will post 4.07 earnings per share for the current year.

H.B. Fuller Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, February 20th. Stockholders of record on Thursday, February 6th were given a $0.2225 dividend. The ex-dividend date was Thursday, February 6th. This represents a $0.89 dividend on an annualized basis and a dividend yield of 1.56%. H.B. Fuller’s payout ratio is 38.53%.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. MetLife Investment Management LLC grew its stake in H.B. Fuller by 4.7% in the 4th quarter. MetLife Investment Management LLC now owns 33,058 shares of the specialty chemicals company’s stock valued at $2,231,000 after buying an additional 1,472 shares during the last quarter. Sterling Capital Management LLC grew its position in shares of H.B. Fuller by 731.1% in the fourth quarter. Sterling Capital Management LLC now owns 1,255 shares of the specialty chemicals company’s stock valued at $85,000 after purchasing an additional 1,104 shares during the last quarter. Kennedy Capital Management LLC increased its stake in shares of H.B. Fuller by 13.4% during the fourth quarter. Kennedy Capital Management LLC now owns 127,896 shares of the specialty chemicals company’s stock worth $8,630,000 after purchasing an additional 15,100 shares during the period. New Age Alpha Advisors LLC bought a new position in shares of H.B. Fuller during the fourth quarter worth approximately $465,000. Finally, KLP Kapitalforvaltning AS acquired a new stake in H.B. Fuller during the 4th quarter worth approximately $783,000. 95.93% of the stock is owned by institutional investors and hedge funds.

About H.B. Fuller

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.